BBT Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
ACM
RC
BC
BFA
LAM
SFM
BIT
BBT Capital Management's ANGO Position: Q4 2014 in Review
BBT Capital Management sold out of AngioDynamics (ANGO) in Q4 2014, closing a stake of 171,412 shares — an estimated $2.35M sold.
BBT Capital Management first reported a position in ANGO in Q3 2013 and held it in 5 quarters. The position peaked at $3.2M in Q1 2014. 132 funds tracked by Wall St. Rank hold ANGO as of Q4 2014.
- BBT Capital Management reported no remaining AngioDynamics position as of Q4 2014 after selling out during the quarter.
- BBT Capital Management sold 171,412 AngioDynamics shares in Q4 2014, an estimated $2.35M.
- BBT Capital Management first reported a position in AngioDynamics in Q3 2013 and held it in 5 quarters.
- BBT Capital Management's AngioDynamics position peaked at $3.2M in Q1 2014.
- 132 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2014.
Based on BBT Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.